Details

NameSymbolSector
MARKSANS PHARMA LTD.MARKSANSPharmaceuticals
Open
301.15
High
336.6
Low
300.75
Close
333
Volume
20243407
Exchange
nse
Time
14-Aug-2026

Outlook

Score:  

5.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Marksans Pharma is  
Long Body
Estimated Stoploss of Marksans Pharma is ₹  
300.75
Marksans Pharma has a  
Bullishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Marksans Pharma maybe  
Unpredictableℹ
, but keep a lookout for rise in price. 

Trend

Marksans Pharma is in  
Sideways trendℹ
. 
Price of Marksans Pharma is  
Upℹ
 by  

26.5

%. 
Target
Buy @ 

200.97

Sell @ 

302.23

Current @ 

333

Volume

The trades of Marksans Pharma have been in  
Immenseℹ
 volume. 
The volume trades for Marksans Pharma are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Marksans Pharma is  

Up

 by  

389.61

% 

Valuation

The current market price of Marksans Pharma is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3239cr and total assets worth ₹ 3239cr, the balance sheet of Marksans Pharma is:  
Balancedℹ
. 
Cashflow
Marksans Pharma has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 92cr

. It is  
Upℹ
 by  

360

%. 

(*Mar 2025)

64.38% i.e. ₹ 206cr earned in operatingℹ
15.31% i.e. ₹ 49cr spent in investingℹ
20.31% i.e. ₹ 65cr spent in financingℹ
0% in otherℹ
Marksans Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 20cr

. It is  
Downℹ
 by  

88.64

%. 

(*Mar 2024)

52.51% i.e. ₹ 230cr earned in operatingℹ
31.96% i.e. ₹ 140cr spent in investingℹ
15.53% i.e. ₹ 68cr spent in financingℹ
0% in otherℹ
Income
The income of Marksans Pharma is  

₹ 741cr

 and  

Profit

 is :  

₹ 99cr

(*Sep 2025)

Marksans Pharma Profit is up by:  

70.69

% and Income is Up by:  

18.56

% 

(*Sep 2025)

The income of Marksans Pharma is  

₹ 625cr

 and  

Profit

 is :  

₹ 58cr

(*Jun 2025)

Marksans Pharma Profit is down by:  

35.56

% and Income is Down by:  

13.67

% 

(*Jun 2025)

The income of Marksans Pharma is  

₹ 724cr

 and  

Profit

 is :  

₹ 90cr

(*Mar 2025)

Marksans Pharma Profit is down by:  

14.29

% and Income is Up by:  

2.12

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.